To this aim, we used human cancer microarray, evaluated CSE1L expression by using a semiquantitative scale of immunoreactive score and examined whether TAZ was detected in the nucleus in human cancers with high levels of CSE1L (Fig. S9). This evidence concerns the gene WWTR1 and cancer.